Skip to main content
. 2021 Feb 22;6(4):e139946. doi: 10.1172/jci.insight.139946

Figure 3. InsrT1150A mice retain insulin’s ability to suppress WAT lipolysis after 7-day HFD.

Figure 3

(A) Plasma NEFA under basal (overnight fasting) and hyperinsulinemic-euglycemic clamp conditions. (B) Insulin’s suppression of plasma NEFA during the hyperinsulinemic-euglycemic clamp. (C and D) Whole-body glycerol turnover and its suppression by insulin during the hyperinsulinemic-euglycemic clamp. (E and F) Whole-body fatty acid turnover and its suppression by insulin during the hyperinsulinemic-euglycemic clamp. In all panels, data are the mean ± SEM of n = 5–6 per group, with comparisons by 2-tailed unpaired Student’s t test. *P < 0.05, **P < 0.01.